Skip to content
value.today

Medicalgorithmics S.A.: peers

Change the peers

Medicalgorithmics S.A. beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.

Medicalgorithmics S.A., Genomtec S.A., Nano-X Imaging Ltd., Senzime AB (publ), Pulsenmore Ltd.: the market cap on file is more than 60 days old or a last known value (no market-data feed for their exchanges yet), so their valuation multiples and yields are shown but not ranked.

Side by side#

Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.

Medicalgorithmics S.A., Genomtec S.A., Hyperfine, Inc., Nano-X Imaging Ltd., Outset Medical, Inc., Pulmonx Corporation, Senzime AB (publ), Pulsenmore Ltd. side by side: each figure with its period and source, its rank among these companies and its percentile in the company's sector and country
MeasureMedicalgorithmics S.A.base
MDG.WA · 🇵🇱 PL
Percentile in Healthcare
Percentile in Poland
Genomtec S.A.
GMT.WA · 🇵🇱 PL
Percentile in Healthcare
Percentile in Poland
Hyperfine, Inc.
HYPR · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Nano-X Imaging Ltd.
NNOX · 🇮🇱 IL
Percentile in Healthcare
Percentile in Israel
Outset Medical, Inc.
OM · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Pulmonx Corporation
LUNG · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Senzime AB (publ)
SEZI.ST · 🇸🇪 SE
Percentile in Healthcare
Percentile in Sweden
Pulsenmore Ltd.
PULS.TA · 🇮🇱 IL
Percentile in Healthcare
Percentile in Israel
Group median
Size
Market cap (Better neither way: ranked highest first)$75 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one6th of 8$31 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one8th of 8$78 MOct 23, 2026 · Market data5th of 8$70 MAug 1, 2026 · Market data7th of 8$82 MOct 28, 2026 · Market data4th of 8$86 MOct 28, 2026 · Market data3rd of 8$87 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one2nd of 8$96 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one1st of 8$80 M8 ranked
Revenue (Better neither way: ranked highest first)————$14 MFY2025 · SEC3rd of 6$13 MFY2025 · SEC4th of 6$119 MFY2025 · SEC1st of 6$91 MFY2025 · SEC2nd of 6$11 MFY2025 · ESEF6th of 6$12 MFY2025 · SEC5th of 6$13 M6 ranked
Net income (Higher is better)————$-36 MFY2025 · SEC3rd of 6$-75 MFY2025 · SEC5th of 6$-82 MFY2025 · SEC6th of 6$-54 MFY2025 · SEC4th of 6$-14 MFY2025 · ESEF2nd of 6$-5 MFY2025 · SEC1st of 6$-45 M6 ranked
Employees (Better neither way: ranked highest first)————102February 15, 2026 · Profile3rd of 3——518As on 2022 · Profile1st of 3202As on 2020 · Profile2nd of 3————2023 ranked
Growth
Market cap change, 30 days (Higher is better)——————————0.0%30 days to Oct 28, 2026 · Market dataonly one with it————0.0%—
Revenue growth (Higher is better)————————+5.2%FY2025 · SEC5th of 638th46th+15.4%FY2025 · SEC3rd of 660th61st+5.1%FY2025 · SEC6th of 638th46th+8.0%FY2025 · SEC4th of 644th55th+91.2%FY2025 · ESEF2nd of 690th98th+344.4%FY2025 · SEC1st of 698th96th+11.7%6 ranked
Revenue growth, 3 years a year (Higher is better)————————+25.8%FY2025 · SEC1st of 478th89th+14.9%FY2025 · SEC3rd of 464th62nd+1.2%FY2025 · SEC4th of 430th37th+19.0%FY2025 · SEC2nd of 471st84th————————+17.0%4 ranked
Earnings per share growth (Higher is better)————————————————————————————-54.2%FY2025 · SEConly one with it8th22nd-54.2%—
Margins and returns
Gross margin (Higher is better)————————49.8%FY2025 · SEC3rd of 636th63rd-98.2%FY2025 · SEC6th of 61st2nd39.1%FY2025 · SEC4th of 624th50th74.2%FY2025 · SEC2nd of 672nd86th33.3%FY2025 · ESEF5th of 619th41st84.1%FY2025 · SEC1st of 685th93rd44.5%6 ranked
Operating margin (Higher is better)————————-273.4%FY2025 · SEC4th of 513th4th-600.8%FY2025 · SEC5th of 54th5th-55.8%FY2025 · SEC1st of 530th14th-59.3%FY2025 · SEC2nd of 530th14th-117.8%FY2025 · ESEF3rd of 521st7th————-117.8%5 ranked
Net margin (Higher is better)————————-262.3%FY2025 · SEC5th of 612th5th-576.2%FY2025 · SEC6th of 64th4th-68.3%FY2025 · SEC3rd of 627th12th-59.7%FY2025 · SEC2nd of 629th13th-132.1%FY2025 · ESEF4th of 620th5th-39.6%FY2025 · SEC1st of 634th28th-100.2%6 ranked
Free cash flow margin (Higher is better)————————-214.8%FY2025 · SEC5th of 614th4th-345.6%FY2025 · SEC6th of 610th14th-39.5%FY2025 · SEC2nd of 630th13th-36.3%FY2025 · SEC1st of 630th14th-107.5%FY2025 · ESEF4th of 620th3rd-82.5%FY2025 · SEC3rd of 623rd25th-95.0%6 ranked
Return on equity (Higher is better)————————-79.0%FY2025 · SEC5th of 631st13th-45.6%FY2025 · SEC3rd of 646th37th-106.2%FY2025 · SEC6th of 623rd10th-77.2%FY2025 · SEC4th of 631st13th-43.4%FY2025 · ESEF2nd of 647th9th-17.4%FY2025 · SEC1st of 661st43rd-61.4%6 ranked
Valuation
Price to sales (Better neither way: ranked highest first)————————4.1×price Oct 23, 2026 · Market data1st of 352nd71st5.3×price Aug 1, 2026 · Market datanot ranked: old priceold priceold price0.7×price Oct 28, 2026 · Market data3rd of 312th21st1.0×price Oct 28, 2026 · Market data2nd of 316th28th————————1.0×3 ranked
Price to book (Better neither way: ranked highest first)————————1.9×price Oct 23, 2026 · Market data1st of 336th45th0.5×price Aug 1, 2026 · Market datanot ranked: old priceold priceold price0.7×price Oct 28, 2026 · Market data3rd of 311th10th1.6×price Oct 28, 2026 · Market data2nd of 332nd39th————————1.6×3 ranked
Free cash flow yield (Higher is better)————————-37.6%price Oct 23, 2026 · Market data1st of 323rd10th-64.7%price Aug 1, 2026 · Market datanot ranked: old priceold priceold price-57.5%price Oct 28, 2026 · Market data3rd of 316th6th-38.1%price Oct 28, 2026 · Market data2nd of 322nd9th————————-38.1%3 ranked
Financial strength
Debt to equity (Lower is better)————————0.0×FY2025 · SEC1st of 35th3rd————0.8×FY2025 · SEC3rd of 368th59th0.7×FY2025 · SEC2nd of 364th54th————————0.7×3 ranked
Interest cover (Higher is better)————————————————-4.8×FY2025 · SEConly one with it56th31st————————————-4.8×—
Piotroski F-score (Higher is better)————————6 of 9FY2025 · SEC1st of 23 of 9FY2025 · SEC2nd of 2————4.5 of 92 ranked
Scorecard
Scorecard (Higher is better)————9 of 22FY2025 · Scorecard2nd of 65 of 14FY2025 · Scorecard4th of 68 of 22FY2025 · Scorecard3rd of 610 of 22FY2025 · Scorecard1st of 61 of 5FY2025 · Scorecard6th of 62 of 6FY2025 · Scorecard5th of 636% passed6 ranked
Valuation checks (Higher is better)————1 of 5FY2025 · Scorecard3rd of 3——2 of 5FY2025 · Scorecard1st of 32 of 5FY2025 · Scorecard1st of 3————40% passed3 ranked
Growth checks (Higher is better)————4 of 6FY2025 · Scorecard1st of 63 of 5FY2025 · Scorecard3rd of 63 of 6FY2025 · Scorecard4th of 64 of 6FY2025 · Scorecard1st of 61 of 2FY2025 · Scorecard4th of 61 of 2FY2025 · Scorecard4th of 655% passed6 ranked
Profitability checks (Higher is better)————1 of 5FY2025 · Scorecard1st of 61 of 5FY2025 · Scorecard1st of 61 of 5FY2025 · Scorecard1st of 61 of 5FY2025 · Scorecard1st of 60 of 3FY2025 · Scorecard5th of 60 of 2FY2025 · Scorecard5th of 620% passed6 ranked
Financial health checks (Higher is better)————3 of 5FY2025 · Scorecard1st of 51 of 3FY2025 · Scorecard5th of 52 of 5FY2025 · Scorecard4th of 53 of 5FY2025 · Scorecard1st of 5——1 of 2FY2025 · Scorecard3rd of 550% passed5 ranked
Shareholder returns checks (Higher is better)————0 of 1FY2025 · Scorecard1st of 40 of 1FY2025 · Scorecard1st of 40 of 1FY2025 · Scorecard1st of 40 of 1FY2025 · Scorecard1st of 4————0% passed4 ranked
Ownership
Held by institutions (Better neither way: ranked highest first)————19.7%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in3rd of 47.7%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in4th of 464.8%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 461.1%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 4————40.4%4 ranked
Institutions holding (Better neither way: ranked highest first)————872026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 4742026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in4th of 4772026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in3rd of 41012026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 4————824 ranked
Institutional holding, change over the quarter (Better neither way: ranked highest first)——————-12.1 pp2026-Q2 against 2026-Q1 · 13F2nd of 3-4.3 pp2026-Q2 against 2026-Q1 · 13F1st of 3-14.1 pp2026-Q2 against 2026-Q1 · 13F3rd of 3————-12.1 pp3 ranked

Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).

† The market cap behind this figure is more than 60 days old (no market-data feed for that exchange yet): it is shown but not ranked or given a percentile.

Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = Medicalgorithmics S.A.: How market caps are worked out; Genomtec S.A.: How market caps are worked out; Hyperfine, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Nano-X Imaging Ltd.: How market caps are worked out; Outset Medical, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Pulmonx Corporation: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Senzime AB (publ): How market caps are worked out; Pulsenmore Ltd.: How market caps are worked out.

Where each stands in its sector and country: Operating margin#

The dot is the company; the line runs from the 10th to the 90th percentile of all the companies of its sector (or country) with the figure, the box holds the middle half and the tick is the median. Each company's newest fiscal year; figures that divide by the market value only with a market cap at most 60 days old. How percentiles are worked out.

Operating margin: each company's figure and its percentile in its sector and its country
CompanyOperating marginIn its sectorIn its country
Medicalgorithmics S.A.———
Genomtec S.A.———
Hyperfine, Inc.-273.4%FY2025
13th percentile in Healthcaremedian -7.7%, 674 companies
4th percentile in USAmedian 3.5%, 2,594 companies
Nano-X Imaging Ltd.-600.8%FY2025
4th percentile in Healthcaremedian -7.7%, 674 companies
5th percentile in Israelmedian -0.2%, 67 companies
Outset Medical, Inc.-55.8%FY2025
30th percentile in Healthcaremedian -7.7%, 674 companies
14th percentile in USAmedian 3.5%, 2,594 companies
Pulmonx Corporation-59.3%FY2025
30th percentile in Healthcaremedian -7.7%, 674 companies
14th percentile in USAmedian 3.5%, 2,594 companies
Senzime AB (publ)-117.8%FY2025
21st percentile in Healthcaremedian -7.7%, 674 companies
7th percentile in Swedenmedian 8.0%, 128 companies
Pulsenmore Ltd.———

Revenue by fiscal year, and the rank in the group#

Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).

Revenue

$0 M$33 M$65 M$98 M$130 M2019202020212022202320242025Hyperfine, Inc. $14 MNano-X Imaging Ltd. $13 MOutset Medical, Inc. $119 MPulmonx Corporation $91 MSenzime AB (publ) $11 MPulsenmore Ltd. $12 M

Rank in the group

1st2nd3rd4th5th6th20182019202020212022202320242025Hyperfine, Inc.: 3rd of 3 in 2020Hyperfine, Inc.: 3rd of 3 in 2021Hyperfine, Inc.: 4th of 4 in 2022Hyperfine, Inc.: 3rd of 5 in 2023Hyperfine, Inc.: 3rd of 6 in 2024Hyperfine, Inc.: 3rd of 6 in 2025Hyperfine, Inc.Nano-X Imaging Ltd.: 3rd of 4 in 2022Nano-X Imaging Ltd.: 4th of 5 in 2023Nano-X Imaging Ltd.: 4th of 6 in 2024Nano-X Imaging Ltd.: 4th of 6 in 2025Nano-X Imaging Ltd.Outset Medical, Inc.: 2nd of 2 in 2018Outset Medical, Inc.: 2nd of 2 in 2019Outset Medical, Inc.: 1st of 3 in 2020Outset Medical, Inc.: 1st of 3 in 2021Outset Medical, Inc.: 1st of 4 in 2022Outset Medical, Inc.: 1st of 5 in 2023Outset Medical, Inc.: 1st of 6 in 2024Outset Medical, Inc.: 1st of 6 in 2025Outset Medical, Inc.Pulmonx Corporation: 1st of 2 in 2018Pulmonx Corporation: 1st of 2 in 2019Pulmonx Corporation: 2nd of 3 in 2020Pulmonx Corporation: 2nd of 3 in 2021Pulmonx Corporation: 2nd of 4 in 2022Pulmonx Corporation: 2nd of 5 in 2023Pulmonx Corporation: 2nd of 6 in 2024Pulmonx Corporation: 2nd of 6 in 2025Pulmonx CorporationSenzime AB (publ): 5th of 6 in 2024Senzime AB (publ): 6th of 6 in 2025Senzime AB (publ)Pulsenmore Ltd.: 5th of 5 in 2023Pulsenmore Ltd.: 6th of 6 in 2024Pulsenmore Ltd.: 5th of 6 in 2025Pulsenmore Ltd.
Revenue by fiscal year with each company's rank in the group and the source of each figure
Fiscal yearMedicalgorithmics S.A.Genomtec S.A.Hyperfine, Inc.Nano-X Imaging Ltd.Outset Medical, Inc.Pulmonx CorporationSenzime AB (publ)Pulsenmore Ltd.
2025——$14 MSEC3rd$13 MSEC4th$119 MSEC1st$91 MSEC2nd$11 MESEF6th$12 MSEC5th
2024——$13 MSEC3rd$11 MSEC4th$114 MSEC1st$84 MSEC2nd$6 MESEF5th$3 MSEC6th
2023——$11 MSEC3rd$10 MSEC4th$130 MSEC1st$69 MSEC2nd—$2 MSEC5th
2022——$7 MSEC4th$9 MSEC3rd$115 MSEC1st$54 MSEC2nd——
2021——$2 MSEC3rd—$103 MSEC1st$48 MSEC2nd——
2020——$0 MSEC3rd—$50 MSEC1st$33 MSEC2nd——
2019————$15 MSEC2nd$33 MSEC1st——
2018————$2 MSEC2nd$20 MSEC1st——

Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Ed. = The company's annual report, entered by value.today editors; WD = Wikidata, citing the annual report; Cap = value.today market caps (the last of each calendar year). The small ordinal is the rank in the group that year. Hover a figure for its fiscal year end.

Suggested peers of Medicalgorithmics S.A.#

Companies of the same industry, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.

  • Genomtec S.A.GMT.WA · 🇵🇱 Poland
    Same industry: Medical Devices · Similar size: $31 M market cap against $75 M · Same country: Poland
    Market cap $31 M (last known, Jan 5, 2024)
    89 of 100 (industry or sector 50 + size 24 + country 15)
    In the group
  • Hyperfine, Inc.HYPR · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $78 M market cap against $75 M · Ratios of the last two fiscal years on file
    Market cap $78 M (Oct 23, 2026) · revenue $14 M (year to December 2025)
    85 of 100 (industry or sector 50 + size 30 + figures on file 5)
    In the group
  • Nano-X Imaging Ltd.NNOX · 🇮🇱 Israel
    Same industry: Medical Devices · Similar size: $70 M market cap against $75 M · Ratios of the last two fiscal years on file
    Market cap $70 M (Aug 1, 2026) · revenue $13 M (year to December 2025)
    84 of 100 (industry or sector 50 + size 30 + figures on file 5)
    In the group
  • Outset Medical, Inc.OM · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $82 M market cap against $75 M · Ratios of the last two fiscal years on file
    Market cap $82 M (Oct 28, 2026) · revenue $119 M (year to December 2025)
    84 of 100 (industry or sector 50 + size 29 + figures on file 5)
    In the group
  • Pulmonx CorporationLUNG · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $86 M market cap against $75 M · Ratios of the last two fiscal years on file
    Market cap $86 M (Oct 28, 2026) · revenue $91 M (year to December 2025)
    84 of 100 (industry or sector 50 + size 29 + figures on file 5)
    In the group
  • Senzime AB (publ)SEZI.ST · 🇸🇪 Sweden
    Same industry: Medical Devices · Similar size: $87 M market cap against $75 M · Ratios of the last two fiscal years on file
    Market cap $87 M (last known, Jan 5, 2024) · revenue $11 M (year to December 2025)
    84 of 100 (industry or sector 50 + size 29 + figures on file 5)
    In the group
  • Pulsenmore Ltd.PULS.TA · 🇮🇱 Israel
    Same industry: Medical Devices · Similar size: $96 M market cap against $75 M · Ratios of the last two fiscal years on file
    Market cap $96 M (last known, Jan 5, 2024) · revenue $12 M (year to December 2025)
    83 of 100 (industry or sector 50 + size 28 + figures on file 5)
    In the group
  • Neuraxis, Inc.NRXS · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $95 M market cap against $75 M · Ratios of the last two fiscal years on file
    Market cap $95 M (Oct 13, 2026) · revenue $4 M (year to December 2025)
    83 of 100 (industry or sector 50 + size 28 + figures on file 5)
    + Add
  • Apyx Medical CorporationAPYX · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $99 M market cap against $75 M · Ratios of the last two fiscal years on file
    Market cap $99 M (Oct 9, 2026) · revenue $53 M (year to December 2025)
    83 of 100 (industry or sector 50 + size 28 + figures on file 5)
    + Add
  • Sensus Healthcare, Inc.SRTS · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $49 M market cap against $75 M · Ratios of the last two fiscal years on file
    Market cap $49 M (Oct 1, 2026) · revenue $27 M (year to December 2025)
    82 of 100 (industry or sector 50 + size 27 + figures on file 5)
    + Add
  • Precision Optics Corporation, Inc.POCI · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $48 M market cap against $75 M · Ratios of the last two fiscal years on file
    Market cap $48 M (Aug 1, 2026) · revenue $32 M (year to June 2026)
    82 of 100 (industry or sector 50 + size 27 + figures on file 5)
    + Add
  • CVRx, Inc.CVRX · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $48 M market cap against $75 M · Ratios of the last two fiscal years on file
    Market cap $48 M (Oct 9, 2026) · revenue $57 M (year to December 2025)
    82 of 100 (industry or sector 50 + size 27 + figures on file 5)
    + Add

Any figure over the years, other peers or a saved group: open this group in the peer workspace.